An Analysis of Droxil® Drug: Advantages, Limitations and Justification

Verified

Added on  2020/05/16

|4
|820
|64
Report
AI Summary
This report provides an analysis of Droxil®, a significant nanoparticle drug approved by the FDA, focusing on its advantages and limitations. Droxil® utilizes doxorubicin as its active pharmaceutical ingredient and DSPE-PEG for enhanced liposome circulation. The report highlights advantages such as high resistance to temperature changes and content leakages, stable remote loading of doxorubicin, and faster drug release in tumor interstitial fluid. However, it also discusses limitations including complement activation leading to pseudo-allergy and potential for skin accumulation due to long circulation time. The report justifies the importance of understanding Droxil's properties for its effective and safe application, and concludes by mentioning ongoing research aimed at reducing limitations and expanding its therapeutic applications, including combinations with radiofrequency ablation and further studies to overcome side effects.
Document Page
1
Name:
Course:
Professor:
Date:
Contents
1. Introduction and literature review..............1
2. Advantages and limitations........................2
3. Justification...............................................2
4. Conclusion.................................................3
5. References.....................................................3
1. Introduction and literature review
Modern medicines and drugs have
found their way through the new
interventions. The drugs have come to solve
the various challenges in the medical
industry. With their implementation and use,
the nanoparticle drugs have their own merits
and challenges in their use as well as the
available drug delivery formulations1.
Droxil® is one of the major nanoparticle
drug which has found its way in the medical
tabler-icon-diamond-filled.svg

Paraphrase This Document

Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
Document Page
2
arena. Droxil® is a nano-drug, which is
approved by FDA. In addition, Droxil ® is
well characterized with active
pharmaceutical ingredients (API) of
doxorubicin2. Also, Droxil® has DSPE-PEG
which acts as a steric stabilizer and enhances
the liposome circulation time. The drug has
been used in treatment of ovarian cancer,
AIDS related Kaposi’s sarcoma, myeloma
and Metastatic breast cancer among other
illnesses. In relation to the drug and its drug
delivery formulation, there are several
merits and limitations which have come with
its use. This paper will look at the key
advantages and limitations which are
experienced Droxil® is used and also related
advantages and limitations during the drug
delivery formulation.
2. Advantages and limitations
First, Droxil® is HSPC related nano-
drug, which is liposome’s matrix. The drug
has high resistance to the liposome
membrane and temperature changes as well
as the content leakages from the liposome4.
The resistance is achieved from the high
cholesterol available at high mole
percentage. This helps the drug to function
well at different conditions. Additionally,
the drug has high and stable remote loading
of doxorubicin, which is driven by a trans-
membrane of ammonium sulfate. Due to the
remote loading, the drug is able to attain
100% drug loading leading to formation of
intra-liposomal nano-crystals of
doxorubicin-sulfate, which have increased
length of liposome diameter3. In addition,
another key advantage is the faster release of
doxorubicin in tumor interstitial fluid. This
advantage ensures that the drug is released
at the perfect position in the tumors and
ensures that the treatment effect is felt. The
reliability of the formulation is one of the
major advantages which this method brings
on board. The delivery methods for the
drugs need to be more reliable to help
coming up with effective treatment methods.
Document Page
3
Droxil® is a particle drug and this is
able to result to complement activation for
the pseudo-allergy2. The side effect is able
to limit the application of the drug in many
cases. Due to the allergy, many patients are
unable to use the drug and thus limiting its
application. Another key limitation of
Droxil® results from the long circulation
time. This is able to result to accumulation
in the skin and therefore leading to both
hand and foot syndrome.
3. Justification
The look on the advantages and
limitations of Droxil® is important. This
ensures that the proper use of the drug is
achieved. In addition, the advantages and
limitation helps to provide ways on which
the drug can be delivered and handled at
different cases. Moreover, the drug’s
advantages and limitations helps in
understanding of the compositions of the
drug and the way it can be used properly.
4. Conclusion
In conclusion, Droxil® has been
developed with key advantages in their use.
Nevertheless, the drug has had some key
limitations. The further combinations are
being carried out to enhance the heating,
which can be achieved by radiofrequency
ablation. This combination is being
researched to enhance the future application
of the drug. The improvements are
important to ensure that the limitations are
further reduced and the application of the
drug is enlarged. In addition, further studies
are being done to overcome the available
side effects which limit the drug use.
5. References
(1) Barenholz, Y. (2016). Handbook of
Clinical Nanomedicine, ed. R. Bawa, G.
Audette and I. Rubinstein, Pan Stanford
Publishing, Singapore, pp. 827–906.
(2 ) www.doxils.com.
Document Page
4
(3) Szebeni, J. Muggia, F. Gabizon A. and
Barenholz, Y. (2011) Adv. Drug
Delivery Rev., 63, 1020.
(4) Barenholz, Y. and Amselem, S. (2013).
Liposome Technology, in Liposome
Preparation and Related Techniques,
ed. G. Gregoriadis, CRC Press, Boca
Raton, FL, 2nd edn, vol. I, pp. 527–
616.
chevron_up_icon
1 out of 4
circle_padding
hide_on_mobile
zoom_out_icon
[object Object]